Adynxx, Inc.

Company Listings from SPi: Adynxx, Inc.

You are here: Home >> SPi Company Listings >> Adynxx, Inc.

 

Adynxx, Inc.

Website:
http://

Search for other references to "adynxx" on SPi News

Latest Adynxx, Inc. News

Adynxx Reports Third Quarter 2019 Financial Results SAN FRANCISCO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy t...... 11:00 GMT Thursday 14th November 2019

Adynxx Receives NIH HEAL Initiative Funding Award for Development of Second Non-Opioid Pain Therapeutic SAN FRANCISCO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy t...... 13:00 GMT Wednesday 2nd October 2019

Adynxx Reports Second Quarter 2019 Financial Results SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy t...... 12:00 GMT Wednesday 14th August 2019

Adynxx Adds Gregory J. Flesher to Board of Directors, Completes Up-listing to OTCQB Market SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy t...... 11:00 GMT Monday 22nd July 2019

Adynxx Stock to Move to OTC Market Following Receipt of Nasdaq Delisting Notice SAN FRANCISCO, June 12, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (Nasdaq: ADYX), a clinical-stage biopharmaceutical company leading the development of transcription factor deco...... 17:32 GMT Wednesday 12th June 2019

Adynxx Announces Payment Date of Special Cash Dividend Previously Announced by Alliqua BioMedical SAN FRANCISCO, May 10, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc., (Nasdaq:ADYX), a clinical-stage biopharmaceutical company leading the development of transcription factor decoy tech...... 11:00 GMT Friday 10th May 2019

Adynxx, Inc. Receives Nasdaq Notice of Delisting or Failure to Satisfy an Initial Listing Rule or Standard SAN FRANCISCO, May 09, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (Nasdaq:ADYX), a clinical-stage biopharmaceutical company leading the development of transcription factor decoy techn...... 22:30 GMT Thursday 9th May 2019

Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors SAN FRANCISCO, May 06, 2019 (GLOBE NEWSWIRE) --  Adynxx, Inc. (Nasdaq: ADYX), a clinical-stage biopharmaceutical company leading the development of transcription factor decoy te...... 11:00 GMT Monday 6th May 2019

Adynxx Announces Merger Agreement with Alliqua BioMedical and Provides Business and Clinical Update SAN FRANCISCO, April 22, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of p...... 13:00 GMT Monday 22nd April 2019

Buy Adynxx, Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us